Stuart Edwards of PricewaterhouseCoopers, Australia, believes courts will favour traditional transactional transfer pricing methods rather than bottom line profits methods in the wake of the landmark Roche decision.
Unlock this content.
The content you are trying to view is exclusive to our subscribers.